Oaktree Acquisition Corp. III Life Sciences (OACC) Shares Outstanding (Weighted Average) (2024 - 2026)
Oaktree Acquisition Corp. III Life Sciences filings provide 3 years of Shares Outstanding (Weighted Average) readings, the most recent being $5.4 million for Q1 2026.
- Quarterly Shares Outstanding (Weighted Average) changed 0.0% to $5.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $5.4 million through Mar 2026, changed 0.0% year-over-year, with the annual reading at $4.0 million for FY2025, 15.84% down from the prior year.
- Shares Outstanding (Weighted Average) hit $5.4 million in Q1 2026 for Oaktree Acquisition Corp. III Life Sciences, up from $4.0 million in the prior quarter.
- Across five years, Shares Outstanding (Weighted Average) topped out at $19.2 million in Q2 2025 and bottomed at $4.0 million in Q4 2025.
- Average Shares Outstanding (Weighted Average) over 3 years is $9.6 million, with a median of $5.4 million recorded in 2025.
- The largest annual shift saw Shares Outstanding (Weighted Average) fell 15.84% in 2025 before it changed 0.0% in 2026.
- Oaktree Acquisition Corp. III Life Sciences' Shares Outstanding (Weighted Average) stood at $4.7 million in 2024, then decreased by 15.84% to $4.0 million in 2025, then surged by 36.07% to $5.4 million in 2026.
- Per Business Quant, the three most recent readings for OACC's Shares Outstanding (Weighted Average) are $5.4 million (Q1 2026), $4.0 million (Q4 2025), and $19.2 million (Q3 2025).